Smita Pakhale1,2, Saania Tariq3, Nina Huynh3, Sadia Jama3,4, Tina Kaur3, Catherine Charron5,4, Kelly Florence6, Fozia Nur3, Margaret Ella Bustamante-Bawagan3, Ted Bignell6, Robert Boyd7, Joanne Haddad8, Tetyana Kendzerska5,3, Gonzalo Alvarez5,3. 1. Department of Medicine, The Ottawa Hospital, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada. spakhale@ohri.ca. 2. The Ottawa Hospital Research Institute (OHRI), Ottawa, Canada. spakhale@ohri.ca. 3. The Ottawa Hospital Research Institute (OHRI), Ottawa, Canada. 4. University of Ottawa, Ottawa, Canada. 5. Department of Medicine, The Ottawa Hospital, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada. 6. Community (peer) Researcher, The Bridge Engagement Centre, Ottawa, Canada. 7. Oasis, Sandy Hill Community Health Centre, Ottawa, Canada. 8. Canadian Mental Health Association, The Ottawa Branch, Ottawa, Canada.
Abstract
BACKGROUND: Globally the burden of Obstructive Lung Diseases (OLD) is growing, however its effect on urban poor populations with the high prevalence of tobacco dependence is virtually unknown. The purpose of this project is to estimate the prevalence and burden of OLD in the urban, low-income populations of Ottawa, Canada. METHODS: The study presented in this paper was part of the PROMPT (Management and Point-of-Care for Tobacco Dependence) project; a prospective cohort study in a community-based setting (n = 80) with meaningful Patient Engagement from design to dissemination. Spirometry data, standardized questionnaires and semi-structured interviews from PROMPT were interpreted to understand the lung function, disease burden and social determinants (respectively) in this population. RESULTS: The prevalence of OLD among those who completed spirometry (N = 64) was 45-59%. Generic and disease-specific quality of life was generally poor in all PROMPT participants, even those without OLD, highlighting the higher disease burden this vulnerable population faces. Quality of life was impacted by two major themes, including i) socioeconomic status and stress and ii) social networks and related experiences of trauma. CONCLUSION: The prevalence and disease burden of OLD is significantly higher in Ottawa's urban poor population than what is observed in the general Canadian population who smoke, suggesting an etiological role of the social determinants of health. This urges the need for comprehensive care programs addressing up-stream factors leading to OLDs, including poor access and utilization of preventive healthcare addressing the social determinants of health. TRIAL REGISTRATION: ClinicalTrails.gov - NCT03626064 , Retrospective registered: August 2018.
BACKGROUND: Globally the burden of Obstructive Lung Diseases (OLD) is growing, however its effect on urban poor populations with the high prevalence of tobacco dependence is virtually unknown. The purpose of this project is to estimate the prevalence and burden of OLD in the urban, low-income populations of Ottawa, Canada. METHODS: The study presented in this paper was part of the PROMPT (Management and Point-of-Care for Tobacco Dependence) project; a prospective cohort study in a community-based setting (n = 80) with meaningful Patient Engagement from design to dissemination. Spirometry data, standardized questionnaires and semi-structured interviews from PROMPT were interpreted to understand the lung function, disease burden and social determinants (respectively) in this population. RESULTS: The prevalence of OLD among those who completed spirometry (N = 64) was 45-59%. Generic and disease-specific quality of life was generally poor in all PROMPT participants, even those without OLD, highlighting the higher disease burden this vulnerable population faces. Quality of life was impacted by two major themes, including i) socioeconomic status and stress and ii) social networks and related experiences of trauma. CONCLUSION: The prevalence and disease burden of OLD is significantly higher in Ottawa's urban poor population than what is observed in the general Canadian population who smoke, suggesting an etiological role of the social determinants of health. This urges the need for comprehensive care programs addressing up-stream factors leading to OLDs, including poor access and utilization of preventive healthcare addressing the social determinants of health. TRIAL REGISTRATION: ClinicalTrails.gov - NCT03626064 , Retrospective registered: August 2018.
Entities:
Keywords:
Obstructive lung disease; Social determinants of health; Urban poor
Authors: Wouter van Dijk; Wan Tan; Pei Li; Best Guo; Summer Li; Andrea Benedetti; Jean Bourbeau Journal: Ann Fam Med Date: 2015 Jan-Feb Impact factor: 5.166
Authors: W W Wiebel; A Jimenez; W Johnson; L Ouellet; B Jovanovic; T Lampinen; J Murray; M U O'Brien Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1996-07
Authors: Matthew Preteroti; G Alex Whitmore; Katherine L Vandemheen; J Mark FitzGerald; Catherine Lemière; Louis-Philippe Boulet; Erika Penz; Stephen K Field; Samir Gupta; R Andrew McIvor; Irvin Mayers; Paul Hernandez; Diane Lougheed; Martha Ainslie; Christopher Licskai; Tanweer Azher; Ian Fraser; Masoud Mahdavian; Shawn D Aaron Journal: Eur Respir J Date: 2020-06-18 Impact factor: 16.671
Authors: M D Eisner; P D Blanc; T A Omachi; E H Yelin; S Sidney; P P Katz; L M Ackerson; G Sanchez; Irina Tolstykh; C Iribarren Journal: J Epidemiol Community Health Date: 2009-10-23 Impact factor: 3.710
Authors: Claus F Vogelmeier; Gerard J Criner; Fernando J Martinez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agusti Journal: Respirology Date: 2017-03-07 Impact factor: 6.424
Authors: Niran Argintaru; Catharine Chambers; Evie Gogosis; Susan Farrell; Anita Palepu; Fran Klodawsky; Stephen W Hwang Journal: BMC Public Health Date: 2013-06-13 Impact factor: 3.295
Authors: Silvia Stringhini; Cristian Carmeli; Markus Jokela; Mauricio Avendaño; Peter Muennig; Florence Guida; Fulvio Ricceri; Angelo d'Errico; Henrique Barros; Murielle Bochud; Marc Chadeau-Hyam; Françoise Clavel-Chapelon; Giuseppe Costa; Cyrille Delpierre; Silvia Fraga; Marcel Goldberg; Graham G Giles; Vittorio Krogh; Michelle Kelly-Irving; Richard Layte; Aurélie M Lasserre; Michael G Marmot; Martin Preisig; Martin J Shipley; Peter Vollenweider; Marie Zins; Ichiro Kawachi; Andrew Steptoe; Johan P Mackenbach; Paolo Vineis; Mika Kivimäki Journal: Lancet Date: 2017-02-01 Impact factor: 202.731